FDA Hits Guardian Drug for Lack of Quality Controls, Secure Data Post author:Sam Post published:April 11, 2017 Post category:Drug Industry Daily The FDA cited Guardian Drug Company over quality and data storage issues. Source: Drug Industry Daily You Might Also Like Medtech Petitions FDA for Permission to Change Dosage in ANDA for Generic Excedrin February 14, 2018 Skyhawk Teams With Sanofi on Oncology and Immunology Targets in Deal Worth Potentially $2 Billion July 6, 2022 FDA Issues Guidance on ICH Good Clinical Practices February 28, 2018
Skyhawk Teams With Sanofi on Oncology and Immunology Targets in Deal Worth Potentially $2 Billion July 6, 2022
